PERCHERON THERAPEUTICS LIMITED — Director's Dealing 2012

Apr 12, 2012

Appendix 3Y

Rule 3.19A.2

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of Entity:	Antisense Therapeutics Limited	(ASX:ANP)
ACN:	095 060 745

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director:	Mr. Robert W. Moses
Date of Last Notice:	4th October 2011

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving riseto the relevant interest.	Spouse
Date of change	13th April 2012
No. of securities held prior to		Shares	Options
change	Direct	-	240,000
	Indirect	8,000,000	1,744,370
	Total	8,000,000	1,984,370
Class	Ordinary Shares
Number acquired		Shares	Options
	Direct	-	-
	Indirect	1,000,000	-
	Total	1,000,000	-

+ See chapter 19 for defined terms.

Number disposed		Shares	Options
	Direct	-	-
	Indirect	-	-
	Total	-	-
Value/ConsiderationNote: If consideration is non-cash, provide details andestimated valuation	$ 17,000.00
No. of securities held after change		Shares	Options
	Direct	-	240,000
	Indirect	9,000,000	1,744,370
	Total	9,000,000	1,984,370
Nature of changeExample: on-market trade, off-market trade, exerciseof options, issue of securities under dividend	On Market Acquisition

Part 2 – Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder	N/A
(if issued securities)
Date of change	N/A
No. and class of securities to	N/A
which interest related prior to
change
Note: Details are only required for a contract in relationto which the interest has changed
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Note: If consideration is non-cash, provide details and anestimated valuation
Interest after change	N/A

Part 3 - +Closed Period

Were the interests in the securities or contracts detailed above tradedduring a +closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade toproceed during this period?	N/A
If prior written clearance was provided on what date was thisprovided?	N/A

The CFO Solution

13.04.2012

+ See chapter 19 for defined terms.